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Huntington disease (HD) is caused by the expansion of a CAG repeat within the coding region of a novel gene
on 4p16.3. Although the variation in age at onset is partly explained by the size of the expanded repeat, the
unexplained variation in age at onset is strongly heritable ( ), which suggests that other genes modify the2h p 0.56
age at onset of HD. To identify these modiﬁer loci, we performed a 10-cM density genomewide scan in 629 affected
sibling pairs (295 pedigrees and 695 individuals), using ages at onset adjusted for the expanded and normal CAG
repeat sizes. Because all those studied were HD affected, estimates of allele sharing identical by descent at and
around the HD locus were adjusted by a positionally weighted method to correct for the increased allele sharing
at 4p. Suggestive evidence for linkage was found at 4p16 ( ), 6p21–23 ( ), and 6q24–26LOD p 1.93 LOD p 2.29
( ), which may be useful for investigation of genes that modify age at onset of HD.LOD p 2.28
Huntington disease (HD [MIM 143100]), a dominantly
transmitted neurodegenerative disorder that involves the
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basal ganglia and cerebral cortex, typically develops in
midlife but can occur at any age. The characteristic symp-
toms of HD—involuntary choreiform movement (Hunt-
ington 1872), cognitive impairment (White et al. 1992),
and psychiatric disorders (Hayden 1981)—begin insid-
iously and worsen, without periods of remission, until
death. The nature of the underlying defect, an unstable,
expanded CAG repeat within the coding region of a
novel 4p16.3 gene (HDCRG 1993), explains many of
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the puzzling genetic features of the disorder, including
the variable age at onset, the tendency for juvenile dis-
ease to be inherited from fathers, and the appearance of
new mutations.
Many studies have examined the relationship of the
CAG repeat to age at onset for motor symptoms in HD
(Andrew et al. 1993; Duyao et al. 1993; Snell et al. 1993;
Ranen et al. 1995; Brinkman et al. 1997), and it is com-
monly recognized that the correlation between repeat size
and age at onset accounts for ∼70% of the variation in
age at onset. Our recent studies and those of others suggest
that the remaining variation in age at onset of HD is
strongly heritable (Djousse´ et al. 2003). These ﬁndings
indicate that the onset of HD is substantially inﬂuenced
by factors other than repeat size, and other modiﬁer genes
may determine the remaining variation in age at onset.
To identify genetic modiﬁers that inﬂuence age at onset
of motor symptoms of HD, siblings affected with HD
were ascertained from 16 clinical sites specializing in HD.
Neurologists or psychiatrists from the participating sites
examined and conﬁrmed the HD diagnosis for each of
the index cases and affected siblings. The Mammalian
Genotyping Service typed 403 autosomalmarkers (Set 10,
Marshﬁeld Medical Research Foundation) in 722 in-
dividuals from 645 sibling pairs affected with HD in
303 sibships. The genotyping data were ﬁrst evaluated
by the sib_kin program in the ASPEX package to verify
sibling relationships. Sixteen pairs in 8 sibships, reported
as full sibs but not conﬁrmed as such, were deleted from
subsequent analyses, which left 629 sibling pairs in 295
families. Mendelian inconsistencies were then identiﬁed
using GENTEST, a precursor of INFER, in the PEDSYS
package. Genotypes for the entire nuclear family were
deleted for the particular marker when an inconsistency
was detected. A total of 411 genotyping errors was de-
tected, for a 0.15% error rate.
The quantitative trait utilized in linkage analysis was
adjusted for the effects of the CAG repeat expansion on
age at onset of motor symptoms. The variability in age
at onset attributable to the CAG repeat number was ad-
justed by linear regression. The relationships of age at
onset to the HD repeat size is best represented by a log-
arithmic relationship (Duyao et al. 1993; Ranen et al.
1995; Brinkman et al. 1997). Regression analysis was
performed using the logarithmically transformed age at
onset as the dependent variable and the size of (a) normal
CAG repeat, (b) expanded CAG repeat, and (c) their in-
teraction as independent variables a [log (onset) p
  #b (HD)CAG b (Normal)CAG b (HD)CAG1 2 3
(Djousse´ et al. 2003).(Normal)CAG]
Linkage analysis of these data uses age at onset ofmotor
symptoms as the phenotype of interest. Cases with 36
repeats were designated “HD mutation carriers,” in ac-
cordance with published associations with disease ex-
pression (Duyao et al. 1993). Age at onset was known
for all HD-affected individuals. Thirty-four unaffected
persons were also included in the analysis to assist with
identical-by-descent (IBD) calculation; age at onset was
coded as “missing” for all unaffected individuals. Vari-
ance-component linkage analysis to age at onset was
performed using GENEHUNTER (version 2.1) (Kruglyak
et al. 1996; Pratt et al. 2000).
The power to detect linkage in our sample of 629 af-
fected sibling pairs depends on the amount of the varia-
tion in age at onset that is explained by a single locus.
We have 69% power to detect a LOD score of 3.0 if the
locus explains 35% of the variance in age at onset but
only 40% power to detect a LOD of 3.0 if the locus
explains 30% of the variance in age at onset. We have
60% power to detect a LOD of 2.3 if the locus explains
30% of the variance in the age at onset and 83% power
to detect a LOD of 2.3 if the locus explains 35% of the
variance in age at onset. Thus, we have power to detect
loci that may be expected to explain a substantial amount
of the variance in age at onset of HD.
Linkage results are presented in ﬁgure 1 and summa-
rized in table 1. Ten multipoint LOD scores and 13 single-
point LOD scores 11.0 were found on six chromosomes.
The highest multipoint LOD scores were 2.29 on chro-
mosome 6p (33 cM from pter, at marker D6S1959,
6p22), 2.28 on chromosome 6q (138 cM from pter, at
marker GATA184A08, 6q22), and 1.93 on chromosome
4p (7.8 cM from pter, at marker D4S3360, 4p16).
One of the strongest LOD scores is on the tip of chro-
mosome 4 (4p16). Because the Huntington gene locus is
in this region (4p16.3), it was unclear whether the link-
age may be caused by increased allele sharing at the HD
locus in this study of HD-affected family members. Nor-
mally, the expected allele sharing IBD for siblings is that
25% will share no alleles, 50% will share one allele, and
25% will share two alleles. However, because affected
siblings always share the abnormal HD allele, it is ex-
pected that 50% of siblings will share one allele IBD (the
HD allele), and 50% of siblings will share two alleles
(both theHD and normal alleles). Current availablemeth-
ods for the mapping of quantitative traits in sibling pairs
rely on comparing the observed allele sharing for the
polymorphic marker with the expected allele sharing at
the locus under investigation. Thus, estimates of IBD by
these methods will be biased for all positions within 50
cM of the HD gene, but the extent of bias will decrease
with increasing recombination distance from the HD
locus until it converges to the traditional estimate at 50
cM. Here, we evaluated two approaches to accommo-
date this possible bias in linkage analysis. In both ap-
proaches, we ﬁrst deﬁned the expected allele IBD sharing
at the HD locus as “0% share no alleles,” “50% share
one allele,” and “50% share two alleles.” We also modi-
ﬁed methods to estimate the allele sharing IBD at the
HD locus for each pair within 50 cM of the HD gene.
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Figure 1 LOD score plots from multipoint variance component analyses of the whole genome in age at onset of HD. Peak LOD score
11.0 are summarized in table 1.
For the positionally weighted approach, each locus
or marker under investigation is weighted on the basis
of its distance from the HD locus. A portion of the
original z0 estimate is distributed to z1 or z2 estimates.
The distribution of z0 to z1 and z2 depends on two
factors. The ﬁrst is a weighted factor that is based on
the distance from the HD locus. The distributed por-
tion of z0 is weighted by a linear function of distance
in cM. As the distance from the HD locus increases,
the chance of recombination increases, and the portion
of z0 allocated to z1 or z2 decreases. The distributed
and the remaining z0 (adjusted z0, ) couldz [D (x)] A[x]0 z0 z0
be described as follows: andA (x) p z # x/50z0 0
Dz0 , where x is the distance in cM(x) p z  A (x)0 z0
from the HD locus and may vary from 0 cM—where
all of z0 is distributed to either z1 or z2—to 50
cM—where none of z0 is distributed to either z1 or z2.
The second factor is determined by the allele sharing
IBD at the HD locus and designates the distribution of
. When the original z2 estimate is not equal toz [D (x)]0 z0
0, it means that, for this pair, the allele sharing for the
loci close to the HD locus is likely to be two alleles. Under
this scenario, at the HD locus, all of is allocatedD (x)z0
to z2. However, as the distance from the HD locus in-
creases, the chance of sharing two alleles decreases be-
cause of possible recombination. Therefore, some portion
of would be contributed to z1. When the distanceD (x)z0
reaches 50 cM from the HD locus, the estimates converge
to the original estimates generated by GENEHUNTER.
The following function describes the distribution of
to z1 and z2, when the allele sharing at the HDD (x)z0
locus is 2 (i.e., ).z ( 0 A (x) p z D (x)# 1/2#2 z1 1 z0
and ,(x/50) A (x) p z D (x)# [1 1/2# (x/50)]z2 2 z0
where x is the distance in cM from the HD locus and
may vary from 0 cM—where all of is allocatedD (x)z0
to z2—to 50 cM—where none of the is allocatedD (x)z0
to both z1 and z2. and are the adjustedA (x) A (x)z1 z2
estimates of z1 and z2, respectively, at the x position.
Similar functions could be used for allocating ,D (x)z0
where the original z2 estimate is equal to 0. At the HD
locus, all of is allocated to z1. As the distance fromD (x)z0
the HD locus increases, some portion of is con-D (x)z0
tributed to z1. For half sibs, since they share only one
allele, the affected HD allele, is all contributed toD (x)z0
z1 at any position between the HD locus and 50 cM.
For the linear IBD estimate approach, the estimated
IBD values between 0 cM and 50 cM were adjusted by
a linear function. The IBD values at the HD locus were
adjusted on the basis of the same principle as of the
weighted method. The estimate of z0 at the HD locus is
ﬁxed at 0, since they always share the affectedHD allele,
and z1 depends on the value of the original z2 estimate.
If the original z2 estimate is not equal to 0, which in-
dicates that the sibling pair likely shares two alleles, then
the adjusted z2 estimate is the sum of the original[A (0)]z2
z0 estimate and z2 estimate, and the adjusted z1 estimate
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Table 1
Maximum Multipoint and Single-Point LOD Scores and Flanking Markers for Regions
with Multipoint LOD 1 1.0
CHROMOSOME
SINGLE-POINT LOD SCORE MULTIPOINT LOD SCORE
CYTOGENETIC
LOCATIONLocationa Marker LOD Locationa Max LOD
1 202 D1S518 1.22 196.60 1.43 1q31.1
2 200 D2S1384 1.57 196.90 1.63 2q33.3
237 D2S427 1.38 236.70 1.09 2q37.1
4 0 D4S3360 1.37 7.80 1.93 4p16
13 D4S2366 1.4 … … …
35 D4S3403 1.09 29.64 1.3 4p15
114 D4S2623 .8 107.94 1.3 4q25
5 139 D5S816 1.27 … … …
147 D5S1480 2.02 146.66 1.48 5q31-32
183 D5S211 1.36 … … …
6 34 D6S1959 1.84 33.00 2.29 6p22.3
138 D6S1009 1.28 … … …
146 GATA184A08 1.35 147.12 2.28 6q23-24
18 89 D18S1357 1.74 83.26 1.69 18q22
NOTE.—An ellipsis (…) indicates that the LOD score at the position is !1.0.
a Location is in relation to pter and uses the Marshﬁeld Genetic Map, sex-averaged distances.
remains unchanged (original z1 estimate). If the[A (0)]z1
original z2 estimate is equal to 0, then the sibling pairs
share one allele, and is 1. The allele sharing at 50A (0)z1
cM was estimated by the traditional GENEHUNTER
algorithm and was assumed to be unbiased. Allele shar-
ing between 0 cM and 50 cMwas determined as a simple
linear function as follows: A(x) p A(0) x# [A(0)
, where x is the distance in cM from the HD locusz ]/5050
and may vary from 0 to 50. A(x) is adjusted ,z A (x)0 z0
, or at x position. A(0) is the adjustedz A (x) z A (x)1 z1 2 z2
z0, z1, or z2 at 0 cM. z50 is the estimate of z0, z1, or z2
at 50 cM. In this way, as the distance from the HD gene
increases, the estimate of IBD approaches the estimate at
50 cM in a linear manner.
Before adjustment, the maximum multipoint LOD
score near the HD locus was 1.95 at 5.2 cM (from the
4p telomere), and the single-point LOD was 1.37. By use
of a positionally weighted adjustment, the LOD score
at the HD locus remained essentially unchanged at 1.93
(7.8 cM) for multipoint, and the single-point LOD was
1.51. When we employed a linear adjustment for the
observed IBD estimation, the maximummultipoint LOD
score at the HD locus was 1.67. The single-point esti-
mate—which limits the allele sharing to 0.5 or 1.0, de-
pending on whether siblings shared 1 or 2 alleles—was
1.51. Both approaches resulted in similar LOD scores,
which suggests that the evidence for linkage near the
HD locus is not a consequence of the increased allele
sharing dictated by presence of the disease allele at the
HD locus. The approaches we utilized may be used in
other linkage-analysis studies for modiﬁer genes at dis-
ease loci. These results are consistent with our previous
report that the normal HD allele or a closely linked gene
may inﬂuence age at onset (Farrer et al. 1993).
Our study detected two chromosomal regions that met
genomewide threshold criteria for “suggestive linkage”
( [Lander and Kruglyak 1995; NyholtLOD  2.19
2000]) to age at onset, adjusted for CAG repeat size in
the HD and normal alleles (table 1). One candidate gene
within these regions, distal to the HD locus in 4p16.3,
that may modify age at onset is the corepressor c-termi-
nal–binding protein (CtBP; 4p16.3). CtBP is a transcrip-
tional repressor and may play a role during cellular pro-
liferation. Recently, the CtBP gene was reported to
interact with wild-type huntingtin in the nucleus, and the
polyglutamine expansion in huntingtin reduced this in-
teraction (Kegel et al. 2002). Some studies attempting to
localize the primary site of cellular toxicity of abnormal
huntingtin have suggested that this may occur in the nu-
cleus (Saudou et al. 1998; Peters et al. 1999), which sup-
ports the potential for a modifying role for theCtBP gene.
Recently, the UCHL1 gene, which encodes ubiquitin
carboxyl-terminal hydrolase L1, was reported to inﬂu-
ence age at onset of HD, with the S18Y polymorphisms
accounting for 13% of the variance in age at onset in
a case-and-control-study design (Naze et al. 2002).
UCHL1 (4p14; 51 cM in the Marshﬁeld GeneticsMap)
is proximal to the peak on the tip of chromosome 4
(4p15-16; 0–35 cM) and unlikely to account for the
effect observed.
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Several previous studies have reported that the gluta-
mate receptor gene (GluR6;GRIK2) acts as anHDmodi-
ﬁer (Rubinsztein et al. 1997; MacDonald et al. 1999).
A particular TAA repeat allele in the 3′ UTR of GRIK2
was associated with younger age at onset of HD (Rub-
insztein et al. 1997; MacDonald et al. 1999). When an-
alyzed in conjunction with UCHL1, 7% of the variance
in the age at onset of HD could be attributed to the
GRIK2 genotype variation, 13% to UCHL1, and 16%
to both polymorphisms (Naze et al. 2002). GRIK2
(6q16.3; 112.20 cM in the Marshﬁeld Genetics Map) is
located ∼26 cM proximal to the peak observed here on
chromosome 6 (6q23–24; 138–146 cM).
The ﬁndings of suggestive linkage to chromosomes 4
and 6, as well as marginal evidence for linkage to chro-
mosomes 1, 2, 5 and 18, in a sample of 629 affected
sibling pairs has provided a direction for the identiﬁcation
of candidate modiﬁers for onset of motor symptoms of
HD that now may be explored in more detail. Similarly,
this scan provides a baseline of comparison for genome
scans to be carried out with independent populations
with HD—and possibly other polyglutamine disorders—
to deﬁne whether there is overlap in the chromosomal
regions implicated to contain modiﬁers. Ultimately, dis-
covering the identity of bona ﬁde modiﬁer loci will help
to explain the steps in the HD pathogenetic process and
will provide potential therapeutic targets already vali-
dated to have a relevant effect in human HD.
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